US20250101113A1
University of Texas System
According to various aspects of this disclosure, the present disclosure relates to an antibody or antigen-binding fragment thereof capable of binding to CD94, a chimeric antigen receptor capable of binding to CD94, and engineered T cells containing chimeric antigen receptors capable of binding to …